Sepsis ve Hipovolemik Hipernatremili Olgunun Yoğun Bakım Yönetimi
Özet
Hipernatremi, serum sodyum düzeyinin 145 mmol/L’nin üzerine çıkmasıyla karakterize, özellikle yaşlı ve yoğun bakım hastalarında sık görülen ve yüksek mortalite ile ilişkili bir elektrolit bozukluğudur. Genellikle serbest su kaybının sodyum kaybından fazla olması sonucu gelişir ve hipovolemi, övolemi veya hipervolemi ile ilişkili olabilir. Klinik bulgular çoğunlukla merkezi sinir sistemi etkilenmesine bağlı olup bilinç değişikliği, nöbet ve koma gibi belirtiler görülebilir. Tedavide altta yatan nedenin belirlenmesi, su açığının hesaplanması, uygun sıvı replasmanı ve sodyum düzeltme hızının dikkatli ayarlanması önemlidir. Sepsis ise enfeksiyona karşı düzensiz konak yanıtıyla ortaya çıkan ve hızlı tanı ile tedavi gerektiren yaşamı tehdit eden bir klinik tablodur. Yönetimde erken sıvı resüsitasyonu, kültürlerin alınması ve geniş spektrumlu antibiyotiklerin başlanması temel yaklaşımlardır. Sunduğumuz olguda, diyabet ve hipertansiyon öyküsü olan 73 yaşındaki erkek hasta; hipovolemik hipernatremi, sepsis ve dehidratasyona bağlı akut böbrek yetmezliği tanılarıyla yoğun bakımda izlenmiştir. Rehidrasyon, uygun sıvı tedavisi ve kültür sonucuna göre başlanan meropenem tedavisi ile hastanın sodyum düzeyi kontrollü şekilde düzeltilmiş, diürezi geri dönmüş ve nörolojik bulguları gerileyerek hasta iyileşmiştir. Sonuç olarak, hipernatreminin doğru hızda düzeltilmesi ve sepsisin erken tedavisi mortaliteyi azaltmada kritik öneme sahiptir.
Hypernatremia is an electrolyte disorder characterized by a serum sodium level above 145 mmol/L, frequently observed especially in elderly patients and in intensive care settings, and associated with high mortality. It generally develops as a result of free water loss exceeding sodium loss and may be associated with hypovolemia, euvolemia, or hypervolemia. Clinical findings are mostly related to central nervous system involvement and may include altered consciousness, seizures, and coma. In treatment, identifying the underlying cause, calculating the water deficit, providing appropriate fluid replacement, and carefully adjusting the rate of sodium correction are essential. Sepsis, on the other hand, is a life-threatening clinical condition resulting from a dysregulated host response to infection and requires rapid diagnosis and treatment. Early fluid resuscitation, obtaining cultures, and initiation of broad-spectrum antibiotics are the main approaches in management. In the presented case, a 73-year-old male patient with a history of diabetes and hypertension was followed in the intensive care unit with diagnoses of hypovolemic hypernatremia, sepsis, and dehydration-related acute kidney injury. With rehydration, appropriate fluid therapy, and meropenem treatment initiated according to culture results, the patient’s sodium level was corrected in a controlled manner, diuresis returned, neurological findings regressed, and the patient recovered. In conclusion, correcting hypernatremia at an appropriate rate and early treatment of sepsis are critical in reducing mortality.
Referanslar
Adrogué HJ, Madias NE. Hypernatremia. N Engl J Med. 2000;342(20):1493-1499.
Liamis G, Filippatos TD, Elisaf MS. Evaluation and treatment of hypernatremia: a practical guide for physicians. Postgrad Med 2016;128:299–306.
Arambewela MH, Somasundaram NP, Garusinghe C. Extreme hypernatremia as a probable cause of fatal arrhythmia: a case report. J Med Case Rep 2016;10:272.
Cabassi A, Tedeschi S. Severity of community acquired hypernatremia is an independent predictor of mortality: a matter of water balance and rate of correction. Intern Emerg Med 2017;12:909–911.
Maggiore U, Picetti E, Antonucci E, et al. The relation between the incidence of hypernatremia and mortality in patients with severe traumatic brain injury. Crit Care 2009;13:R110.
Tsipotis E, Price LL, Jaber BL, Madias NE. Hospital-associated hypernatremia spectrum and clinical outcomes in an unselected cohort. Am J Med 2018;131:72–82.
Ates I, Ozkayar N, Toprak G, Yilmaz N, Dede F. Factors associated with mortality in patients presenting to the emergency department with severe hypernatremia. Intern Emerg Med 2016;11:451–459.
Kang MY. Blood electrolyte disturbances during severe hypoglycemia in Korean patients with type 2 diabetes. Korean J Intern Med 2015;30:648–656.
Lindner G, Funk GC. Hypernatremia in critically ill patients. J Crit Care 2013;28:216.
Lindner G, Funk GC, Schwarz C, et al. Hypernatremia in the critically ill is an independent risk factor for mortality. Am J Kidney Dis 2007;50:952–957.
Bataille S, Baralla C, Torro D, et al. Undercorrection of hypernatremia is frequent and associated with mortality. BMC Nephrol 2014;15:37.
Kim SW. Hypernatemia: successful treatment. Electrolyte Blood Press 2006;4:66–71.
Muhsin SA, Mount DB. Diagnosis and treatment of hypernatremia. Best Pract Res Clin Endocrinol Metab 2016;30:189–203.
Lam NN, Minh NTN. Risk factors and outcome of hypernatremia amongst severe adult burn patients. Ann Burns Fire Disasters 2018;31:271–277.
Johnson R, Feehally J, Floege J, Tonelli M. Comprehensive Clinical Nephrology. 6th ed. Edinburgh (UK): Elsevier, 2018.
Sterns RH. Disorders of plasma sodium: causes, consequences, and correction. N Engl J Med 2015;372:55–65.
Strange K. Regulation of solute and water balance and cell volume in the central nervous system. J Am Soc Nephrol 1992;3:12–27.
Koch CA, Fulop T. Clinical aspects of changes in water and sodium homeostasis in the elderly. Rev Endocr Metab Disord 2017;18:49–66.
Arieff AI, Guisado R. Effects on the central nervous system of hypernatremic and hyponatremic states. Kidney Int 1976;10:104–116.
Qian Q. Hypernatremia. Clin J Am Soc Nephrol 2019;14:432–434.
Al-Absi A, Gosmanova EO, Wall BM. A clinical approach to the treatment of chronic hypernatremia. Am J Kidney Dis 2012;60:1032–1038.
Deubner N, Berliner D, Frey A, et al. Dysnatraemia in heart failure. Eur J Heart Fail 2012;14:1147–1154.
Mount DB. Fluid and electrolyte disturbances. In: Loscalzo J, Fauci A, Kasper D, Hauser S, Longo D, Jameson JL, eds. Harrison’s Principles of Internal Medicine. 21st ed. New York (NY): McGraw-Hill Education, 2022.
Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol 2014;170:G1–G47
Lee JW. Fluid and electrolyte disturbances in critically ill patients. Electrolyte Blood Press 2010;8:72–81.
Popli S, Tzamaloukas AH, Ing TS. Osmotic diuresis-induced hypernatremia: better explained by solute-free water clearance or electrolyte-free water clearance? Int Urol Nephrol 2014;46:207–210.
Lindner G, Schwarz C, Funk GC. Osmotic diuresis due to urea as the cause of hypernatraemia in critically ill patients. Nephrol Dial Transplant 2012;27:962–967.
Vadi S, Yim K. Hypernatremia due to urea-induced osmotic diuresis: physiology at the bedside. Indian J Crit Care Med 2018;22:664–669.
Kahn T. Hypernatremia with edema. Arch Intern Med 1999;159:93–98.
Braun MM, Barstow CH, Pyzocha NJ. Diagnosis and management of sodium disorders: hyponatremia and hypernatremia. Am Fam Physician 2015;91:299–307.
Kahn A, Brachet E, Blum D. Controlled fall in natremia and risk of seizures in hypertonic dehydration. Intensive Care Med 1979;5:27–31.
Blum D, Brasseur D, Kahn A, Brachet E. Safe oral rehydration of hypertonic dehydration. J Pediatr Gastroenterol Nutr 1986;5:232–235.
Agrawal V, Agarwal M, Joshi SR, Ghosh AK. Hyponatremia and hypernatremia: disorders of water balance. J Assoc Physicians India 2008;56:956–964.
Ryu JY, Yoon S, Lee J, et al. Efficacy and safety of rapid intermittent bolus compared with slow continuous infusion in patients with severe hypernatremia (SALSA II trial): a study protocol for a randomized controlled trial. Kidney Res Clin Pract 2022;41:508–520.
Alshayeb HM, Showkat A, Babar F, Mangold T, Wall BM. Severe hypernatremia correction rate and mortality in hospitalized patients. Am J Med Sci 2011;341:356–360.
Sterns RH. Evidence for managing hypernatremia: is it just hyponatremia in reverse? Clin J Am Soc Nephrol 2019;14:645–647.
Hoorn EJ. Intravenous fluids: balancing solutions. J Nephrol 2017;30:485–492.
Adrogue HJ, Madias NE. Aiding fluid prescription for the dysnatremias. Intensive Care Med 1997;23:309–316.
Priya G, Kalra S, Dasgupta A, Grewal E. Diabetes insipidus: a pragmatic approach to management. Cureus 2021;13:e12498.
Van De Louw A, Shaffer C, Schaefer E. Early intensive care unit-acquired hypernatremia in severe sepsis patients receiving 0.9% saline fluid resuscitation. Acta Anaesthesiol Scand 2014;58:1007–1014.
Harring TR, Deal NS, Kuo DC. Disorders of sodium and water balance. Emerg Med Clin North Am 2014;32:379–401.
Hoorn EJ, Betjes MG, Weigel J, Zietse R. Hypernatraemia in critically ill patients: too little water and too much salt. Nephrol Dial Transplant 2008;23:1562–1568.
Elixhauser A, Friedman B, Stranges E. Septicemia in U.S. Hospitals, 2009. Agency for Healthcare Research and Quality, Rockville, MD. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb122.pdf (Accessed on February 15, 2013).
Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315:801.
Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med 2021; 49:e1063.
Howell MD, Davis AM. Management of Sepsis and Septic Shock. JAMA 2017; 317:847.
Casserly B, Phillips GS, Schorr C, et al. Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database. Crit Care Med 2015; 43:567.
Tang Y, Choi J, Kim D, et al. Clinical predictors of adverse outcome in severe sepsis patients with lactate 2-4 mM admitted to the hospital. QJM 2015; 108:279.
Haas SA, Lange T, Saugel B, et al. Severe hyperlactatemia, lactate clearance and mortality in unselected critically ill patients. Intensive Care Med 2016; 42:202.
Cheng MP, Stenstrom R, Paquette K, et al. Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis: A Diagnostic Study. Ann Intern Med 2019; 171:547.
Kubo K, Sakuraya M, Sugimoto H, et al. Benefits and Harms of Procalcitonin- or C-Reactive Protein-Guided Antimicrobial Discontinuation in Critically Ill Adults With Sepsis: A Systematic Review and Network Meta-Analysis. Crit Care Med 2024; 52:e522.
Rochwerg B, Alhazzani W, Sindi A, et al. Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med 2014; 161:347.
Brown RM, Wang L, Coston TD, et al. Balanced Crystalloids versus Saline in Sepsis. A Secondary Analysis of the SMART Clinical Trial. Am J Respir Crit Care Med 2019; 200:1487.
Beran A, Altorok N, Srour O, et al. Balanced Crystalloids versus Normal Saline in Adults with Sepsis: A Comprehensive Systematic Review and Meta-Analysis. J Clin Med 2022; 11.
Self WH, Semler MW, Wanderer JP, et al. Balanced Crystalloids versus Saline in Noncritically Ill Adults. N Engl J Med 2018; 378:819.
Semler MW, Self WH, Wanderer JP, et al. Balanced Crystalloids versus Saline in Critically Ill Adults. N Engl J Med 2018; 378:829.
Amoah J, Klein EY, Chiotos K, et al. Administration of a β-Lactam Prior to Vancomycin as the First Dose of Antibiotic Therapy Improves Survival in Patients With Bloodstream Infections. Clin Infect Dis 2022; 75:98.
Giabicani M, Guitard PG, Guerrot D, Grangé S, Teule L, et al. (2015) Successful treatment of extreme hypernatremia by continuous veno-venous hemodiafiltration. Nephrol Ther 11: 492-495.
Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med. 2000;342(20):1493-1499.
Shah MK, Workeneh B, Taffet GE. Hypernatremia in the geriatric population. Clin Interv Aging. 2014;9:1987-1992.
Ilardi A. Diagnostic and therapeutic approach to hypernatremia. Diagnosis (Berl). 2022;9(4):403-410.
